This Vertex Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday

BenzingaJun 27 20:41

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Could Be Less Than A Year Away From Profitability

Simply Wall StJun 27 19:33

Express News | ACADIA Pharmaceuticals Inc : BMO Initiates Coverage With Outperform Rating; Target Price $31

BreakingsJun 27 18:45

ACADIA Pharmaceuticals Initiated at Outperform by BMO Capital

Dow JonesJun 27 17:29

BMO Capital Initiates Coverage On ACADIA Pharmaceuticals With Outperform Rating, Announces Price Target of $31

BenzingaJun 27 17:20

BMO Capital Initiates ACADIA Pharmaceuticals(ACAD.US) With Buy Rating, Announces Target Price $31

BMO Capital analyst Evan Seigerman initiates coverage on $ACADIA Pharmaceuticals(ACAD.US)$ with a buy rating, and sets the target price at $31.According to TipRanks data, the analyst has a success rat

Futu NewsJun 27 04:32 · Ratings